Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs

Nasdaq: What is the current market environment for biotech initial public offerings and biotech listings overall? Saxe: I expect that 2018 will demonstrate positive momentum for biotech listings overall, and specifically on Nasdaq. We predict 30-plus biotech IPOs this year and a strong first half of 2018 …